 On Tuesday, August 11, HTG Molecular Diagnostics NASDAQ: HTGM will report its last quarters earnings. Here is Benzingas preview of the companys release.Earnings and Revenue Sell-side analysts are expecting HTG Molecular Diagnosticss earnings per share to be near -0.08 on sales of 1.79 million. HTG Molecular Diagnostics EPS in the same period a year ago totaled -0.17. Sales were 5.80 million. The Wall Street estimate would represent a 52.94 increase in the companys earnings. Heres how the companys reported EPS has stacked up against analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate -0.10 -0.09 -0.16 -0.15 EPS Actual -0.08 -0.01 -0.15 -0.17 Revenue Estimate 3.04 M 4.85 M 5.47 M 5.56 M Revenue Actual 2.23 M 4.80 M 5.41 M 5.80 M Stock Performance Over the past 52-week period, shares of HTG Molecular Diagnostics have declined 41.13. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.View more earnings on HTGMDont be surprised to see the stock move on comments made during its conference call. HTG Molecular Diagnostics is scheduled to hold the call at 16:30:00 ET and can be accessed here: more from Benzinga 18 Healthcare Stocks Moving In Tuesdays Pre-Market Session 20 Healthcare Stocks Moving In Thursdays Pre-Market Session 20 Healthcare Stocks Moving In Thursdays Pre-Market SessionC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 